You will be redirected to:

Continue
Logo - Kls
Logo - Kls
  • Playbook
  • Services
    Frame clinical development strategies
    Operationalize clinical development
    Implement RWE and Late Phase projects
    Enable life data science boosters
    Reach the next level in digital innovation
  • Insights
  • Technology
  • Careers
  • About us
    Company purpose
    Life science innovation
    Committed Keyrus
    Regulatory compliance
    Investors
    Management team
    Keyrus Group
    Locations

Facilitate data mapping to SDTM by leveraging standardisation and A.I.

Background

Our clients are mid-to-large size healthcare companies based in Europe, willing to fully embrace digital technologies.

Challenge

Our client wanted to mitigate the time and effort required to map the data from their EDC system to the CDISC-SDTM data format.

Approach

- Analysed and challenged current methodologies, - Improved standardisation and reuse of codes from past clinical trials, - Selected a Clinical MetaData Repository system (CMDR) to streamline the data flows and automate most of the manual tasks - Leveraged natural language processing techniques (NLP) on metadata to ease the data mapping procedure

Key results

01
Accelerate the mapping between the EDC data and the SDTM data format ready for submission to authorities.
02
Ease maintenance and update in case of amendments.
03
Make reporting for pharmacovigilance more robust.

Benefits

By promoting process standardization, selecting and integrating new software platforms, and leveraging advanced A.I technologies; Keyrus can help you shorten and harmonise your clinical data management workflows.

Share this key play

whatsapptwitter
linkedinfacebookworkplace

More key plays

Piloting through a pivotal study in cataract eye surgery helping patients recover their vision
Medical device approved for Hearing Loss
Accelerate the compliance process of your product portfolio in line with the new Medical Device Regulation (EU 2017/745)
Accelerate the clinical validation of an anti-Covid treatment, thanks to an agile data management
Lower costs & risks associated with indication extensions, thanks to a robust meta-analysis of clinical data
Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Achieving an end-to-end audit approval from Health Canada
Speed up the development of clinical study documents
Logo - Kls
Headquarters

157 Rue Anatole France 92593 Levallois-Perret

Phone:+33 (0)1 41 34 10 00

LinkedInKlsInstagram
PlaybookServicesInsightsTechnologyCareersAbout us
Company purposeLife science innovationCommitted KeyrusRegulatory complianceInvestorsManagement teamKeyrus GroupLocations
Legal notice & Terms of use
Privacy policy
Data protection